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ABSTRACT 1 
Background. Higher levels of physical activity are associated with a lower risk of cardiovascular 2 
events. Nevertheless, there is debate on the dose-response relationship of exercise and CVD 3 
outcomes and whether high volumes of exercise may accelerate coronary atherosclerosis. We 4 
aimed to determine the relationship between lifelong exercise volumes and coronary 5 
atherosclerosis.   6 
Methods. Middle aged men engaged in competitive or recreational leisure sports underwent a 7 
non-contrast and contrast-enhanced computed tomography scan to assess coronary artery 8 
calcification (CAC) and plaque characteristics. Participants reported lifelong exercise history 9 
patterns. Exercise volumes were multiplied by Metabolic Equivalent of Task (MET) scores to 10 
calculate MET-min/week. Participants were categorized as <1000 MET-min/week, 1000-2000 11 
MET-min/week or >2000 MET-min/week. 12 
Results. 284 men (55±7 years) were included. CAC was present in 150/284 (53%) participants with 13 
a median CAC score of 35.8 [9.3-145.8). Athletes with a lifelong exercise volume >2000 MET-14 
min/week (n=75) had a significantly higher CAC score (9.4 [0-60.9] versus 0 [0-43.5], p=.02) and 15 
prevalence of CAC (68%,ORadjusted=3.2 (95%CI: 1.6-6.6)) and plaque (77%, ORadjusted=3.3 (95%CI: 16 
1.6-7.1)) compared to <1000 MET-min/week (n=88, 43% and 56% respectively). Very vigorous 17 
intensity exercise (≥9 METs) was associated with CAC (ORadjusted=1.47 (95%CI: 1.14-1.91)) and 18 
plaque (ORadjusted=1.56 (95%CI: 1.17-2.08)). Among participants with CAC>0, there was no 19 
difference in CAC score (p=.20), area (p=.21), density (p=.25) and regions of interest (p=.20) across 20 
exercise volume groups. Among participants with plaque, the most active group (>2000 MET-21 
min/week) had a lower prevalence of mixed plaques (48% versus 69%, ORadjusted=0.35 (95%CI: 22 
4 
 
0.15-0.85) and more often had only calcified plaques (38% versus 16%, ORadjusted=3.57 (95%CI: 1 
1.28-9.97)) compared to the least active group (<1000 MET-min/week).  2 
Conclusions. Participants in the >2000 MET-min/week group had a higher prevalence of CAC and 3 
atherosclerotic plaques. The most active group did however have a more benign composition of 4 
plaques, with fewer mixed plaques and more often only calcified plaques. These observations 5 
may explain the increased longevity typical of endurance athletes despite the presence of more 6 
coronary atherosclerotic plaque in the most active participants.   7 
 8 
Keywords: coronary atherosclerosis; coronary artery calcium; exercise; coronary computed 9 
tomography angiography  10 
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CLINICAL PERSPECTIVE 1 
What is new: 2 
- This study improves understanding of coronary atherosclerosis in middle-aged athletes by 3 
analyzing CAC and atherosclerotic plaque characteristics with contrast-enhanced CT in 4 
relation to lifelong exercise.  5 
- Athletes with a high lifelong exercise volume are more likely to have coronary 6 
atherosclerosis, but the most active athletes have a more benign composition of 7 
atherosclerotic plaques, i.e. less mixed and more often only calcified plaques. 8 
What are the clinical implications: 9 
- Physically active persons may have substantial, asymptomatic, coronary atherosclerosis.  10 
- We showed substantial CAC and plaque in very active athletes, which is associated with 11 
an increased risk of cardiac events.  12 
- As the atherosclerotic plaque types had a more benign composition, long-term follow-up 13 
of athletes needs to show whether atherosclerotic burden in athletes confers a similar risk 14 
as in the general population. 15 
- Future studies unravelling the mechanisms leading to higher CAC and plaque prevalence 16 
in very active athletes are warranted. 17 
  18 
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INTRODUCTION 1 
Cardiovascular diseases (CVD) are the leading cause of death worldwide, accounting for >17 2 
million deaths per year1. Atherosclerotic coronary artery disease is the main cause of CVD 3 
morbidity and mortality. Computed tomography (CT) imaging allows assessment of coronary risk 4 
since the extent of coronary artery calcification (CAC) is an indicator of the coronaries’ 5 
atherosclerotic plaque burden and the risk of future cardiovascular events2, 3. Furthermore, 6 
coronary angiography (CTCA) allows assessment and characterization of atherosclerotic plaques, 7 
which significantly determines risk estimation3. 8 
 Higher levels of physical activity are associated with a lower risk of cardiovascular events4, 9 
5 and elite athletes live longer than the general population6. Nevertheless, there is debate on the 10 
dose-response relationship of exercise and CVD outcomes7, 8 and whether high volumes of 11 
exercise may accelerate coronary atherosclerosis9-11. The relationship between physical activity 12 
and coronary atherosclerosis has been studied since 1960, when a post mortem study found a 13 
similar degree of coronary atherosclerosis in sedentary and active men12. Although a recent 14 
German study found no difference in CAC scores between marathon runners (n=108) and age-15 
matched controls (n=864), these athletes had significantly higher CAC scores when compared to 16 
controls (n=216) who were matched for both age and CVD risk factors13. This contrasts with other 17 
observational studies that found either no association14-16 or an inverse relationship17, 18 between 18 
physical activity or fitness and CAC. Prior studies did not examine participants exposed to high 19 
volumes of exercise training for a prolonged period of time. Therefore, the question remains 20 
whether extreme exercise exposure accelerates the development of coronary artery 21 
atherosclerosis and calcification.  22 
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This study sought to determine the relationship between high volumes of exercise and CT 1 
guided assessment of CAC and atherosclerotic plaque characteristics. Others have shown that a 2 
high CAC area is directly associated with CVD risk, but that increased density of CAC is inversely 3 
associated with CVD risk19. Moreover, the type of plaque is important for the risk of cardiac 4 
events3, with a lower risk attributed to calcified plaques compared to non-calcified and mixed 5 
plaques. We hypothesized that athletes that performed more lifelong exercise would 6 
demonstrate similar or higher CAC scores, but with a greater CAC density compared to athletes 7 
performing lower lifelong exercise volumes. We also expected athletes with the highest exercise 8 
volume to have more low-risk calcified plaques instead of non-calcified and mixed plaques. The 9 
enhanced plaque calcification may offset the increased CAC score and contribute to the superior 10 
life expectancy of athletes versus less active peers.  11 
 12 
METHODS 13 
Study population 14 
This is an analysis of the Measuring Athlete’s Risk of Cardiovascular Events (MARC) study, whose 15 
rationale and design have been published previously20. Men aged 45 years or older were eligible 16 
if they were asymptomatic, engaged in competitive or recreational leisure sports, were free of 17 
known CVD and had undergone a sports medical examination with bicycle exercise ECG that 18 
revealed no abnormalities, according to the responsible physician. We included only men because 19 
of their higher probability of coronary atherosclerosis and risk of exercise related cardiac arrest 20 
than women21, 22. Regional sports physicians assisted with recruiting potential participants, as 21 
they provided a flyer detailing the MARC study to athletes that underwent a sports medical 22 
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examination for comprehensive assessment of exercise tolerance. In the Netherlands, athletes 1 
often visit a sports physician either to improve their training patterns by determining their fitness 2 
(VO2 max), (an)aerobic threshold, peak heart rate and peak load (Watt) or to gain reassurance 3 
that they can sport safely. There was therefore no referral or medical condition underlying the 4 
examination in MARC participants. Exclusion criteria were 1) an abnormal sports medical 5 
examination according to the responsible physician, 2) known coronary artery disease, 3) contrast 6 
allergy and 4) renal impairment. The medical ethics committee approved the study and all 7 
participants provided written informed consent before participation. The study was conducted 8 
according to the Declaration of Helsinki. Baseline characteristics were obtained during the sports 9 
medical examination. 10 
 11 
Lifelong exercise volume 12 
Participants reported their lifelong exercise history including type of sport, year started and 13 
stopped, numbers of days a week, months per year, duration of the sessions and the level at 14 
which they performed for every sport. We assigned a metabolic equivalent of task (MET) for all 15 
reported sports23. We calculated the exercise volume per sport by multiplying the MET score for 16 
the specific sport with the reported exercise volume (session duration * frequency/week), 17 
months of practice per year and total years of practice. The lifelong exercise volume represents 18 
the sum of all sports activities between age 12 and the age at study participation and was 19 
expressed in MET-hours/week. We also calculated the average lifetime exercise exposure in MET-20 
hours/week and MET-min/week by dividing the total lifetime exercise volume by age at 21 
participation minus 12 for average exercise volume per year and then divided this number by 52 22 
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for average exercise volume per week (MET-hours/week). MET-min/week was calculated from 1 
MET-hours/week multiplied by 60. Based on the international physical activity recommendation 2 
that individuals perform 500 to 1000 MET-min/week of exercise24, we assigned study participants 3 
to a lifelong exercise volume group of <1000, 1000-2000 or >2000 MET-min/week. Moreover, we 4 
classified per individual the sport with the most lifelong hours as the dominant sport. Finally, we 5 
classified exercise as light (<3 MET), moderate (3-6 MET), vigorous (6-9 MET) or very vigorous (≥ 6 
9 MET) intensity and calculated the average lifetime hours/week of exercise in the specific 7 
intensity ranges. 8 
 9 
Cardiac Computed Tomography 10 
Participants underwent a low dose cardiac CT using a 256-slice CT scanner (Philips Healthcare, 11 
Best, The Netherlands) with electrocardiographic gating according to guidelines25. A non-contrast 12 
CT was acquired to calculate the CAC score (scan parameters 120 kV, 60mAs), followed by CTCA. 13 
The total average radiation dose was 3.9±0.9 mSv (1.0±0.4 mSv for CAC score and 3.0±1.2 mSv 14 
for CTCA). CT scans were processed on a workstation (IntelliSpace Portal, Philips Healthcare) by 15 
experienced technicians, and assessed by two experienced cardiac radiologists who were blinded 16 
to the sports medical examination findings and exercise levels. The American Heart Association 17 
modified 16-segment coronary artery model was used to analyze plaque and CAC characteristics 18 
per segment26, 27.  19 
 20 
Coronary Artery Calcification and plaque characteristics 21 
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The Agatston CAC score was constructed by multiplying the calcified area (mm2) of each plaque 1 
by 1,2,3 or 4 depending on the density of the plaque based on Hounsfield Units (HU), and 2 
summing up all CT slices28. Calcified areas are included in the score when the plaque density was 3 
above 130 Hounsfield Units (HU). Calcified areas received a density score of 1 when density was 4 
between 130 – 200 HU, 2 = 200 – 300 HU, 3 = 300 – 400 and 4 = >400 HU. The number of calcified 5 
areas are indicated by the regions of interest. CAC scores were dichotomized (CAC=0 and CAC>0) 6 
and categorized (0, >0 – 100 and >100). CTCA was used to segment CAC, assess plaque 7 
characteristics of plaques identified by the non-contrast CT scan and for the identification of 8 
plaques with calcification levels below the Hounsfield (<130 HU) threshold. We divided plaques 9 
into 1) calcified, 2) non-calcified, 3) mixed <130HU (detected with CTCA but not with CAC scoring) 10 
and 4) mixed >130 HU (detected with CTCA and CAC scoring) plaques.  11 
 12 
Data analysis 13 
All parameters were visually inspected for normality and checked for kurtosis and skewness. 14 
Continuous variables were reported as mean±SD when normally distributed or as median 15 
[interquartile range] when not normally distributed and categorical variables were presented as 16 
proportions. T-tests were used to compare continuous variables between individuals with CAC=0 17 
versus CAC>0 when data were normally distributed. Mann-Whitney U tests were used to compare 18 
the characteristics of the CAC=0 versus CAC>0 groups when data were not normally distributed. 19 
Pearson Chi-Square tests were used to compare categorical variables. One-way ANOVA with 20 
Bonferroni post-hoc tests were used to compare participant characteristics between the lifelong 21 
exercise volume groups (<1000 / 1000-2000 / >2000 MET-min/week) when data was normally 22 
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distributed, and Kruskall-Wallis 1-way ANOVA tests were used when data were not normally 1 
distributed. Two-way repeated measures ANOVA was performed to describe the distribution of 2 
lifelong exercise patterns per group across age per decade. Binary logistic regression was used to 3 
calculate unadjusted and adjusted odds ratio’s (ORs) for the association between exercise 4 
characteristics (volume / intensity / sport type) and CAC, coronary atherosclerosis and plaque 5 
type presence. Furthermore, we decided a priori to adjust for the following known cardiovascular 6 
risk factors: body mass index, systolic blood pressure, smoking, use of antihypertensive, 7 
cholesterol and family history of coronary heart disease. Additionally, we made a model in which 8 
we also adjusted for use of statins and diabetes, because these factors are known to influence 9 
coronary atherosclerosis29, 30. Moreover, to explore a potential non-linear relationship between 10 
lifetime exercise volume (MET-hours/week) and CAC or plaque, we performed restricted cubic 11 
spline regression analyses. The knots were placed at the 5th, 50th and 95th percentile31, 32. We 12 
performed a test for non-linearity, which compares models with the cubic spline terms and 13 
models with only the linear terms using the likelihood ratio test. Finally, we explored the 14 
association between lifetime exercise volume and CAC characteristics for only those participants 15 
with CAC>0, and the association between exercise characteristics (volume / intensity / sport type) 16 
and plaque characteristics for participants with any coronary atherosclerosis only. Statistical 17 
significance was assumed at p<0.05. Statistical analyses were performed using SPSS Statistics 21 18 
(IBM Corp, Armonk, NY, USA). The cubic spline regression analysis was conducted using SAS 19 
software, version 9.3 (SAS, Cary, NC, USA). 20 
 21 
RESULTS 22 
12 
 
A total of 284 participants from the original study population of n=318 (100% Caucasian) were 1 
included because 27 athletes did not return the lifelong exercise questionnaire and 7 athletes 2 
returned an incomplete questionnaire. CAC characteristics were not different between included 3 
and excluded athletes (data not shown). Frequency of the sports activities and dominant sports 4 
are summarized in Supplemental Table 1. Mean age (±SD) of the study population was 55.0±6.5 5 
years, 150 of the 284 participants (53%) had CAC with a median CAC score of 35.8 [9.3-145.8]. 6 
Average lifetime exercise volume was 2.9 [1.9-4.4] hours/week, resulting in 1356 [851-2030] MET-7 
min/week (Supplemental Table 2).  8 
  Athletes with CAC were older, had higher systolic and diastolic blood pressures, higher 9 
total cholesterol concentrations and more frequently used statins, were former smokers and had 10 
a positive family history for coronary heart disease compared to athletes without CAC 11 
(Supplemental Table 2). Athletes with CAC were also more physically active during their lifetime 12 
compared to athletes without CAC, as evidenced by more years of exercise, exercise 13 
sessions/week, hours/week, MET-min/week and subsequently more lifetime MET-hours. Logistic 14 
regression analyses confirmed the association between lifetime exercise volume (MET-15 
hours/week) and CAC presence, with ORadjusted=1.02 for CAC>0 per MET-hour/week (Table 2). 16 
Specifically, only very vigorous intensity exercise (hours/week) was associated with CAC presence 17 
with ORadjusted=1.47 (95%CI: 1.14 – 1.91). 18 
   Figure 1 provides an overview of lifelong exercise patterns for each exercise 19 
volume group. CAC was more common in athletes with higher lifelong exercise volumes (Table 20 
1). Athletes performing >2000 MET-min/week more frequently had CAC>0 (68%) as compared to 21 
the <1000 MET-min/week group (43%, Table 1, Figure 2 Panel A). CAC scores (9.4 [0-60.9] vs. 0 22 
13 
 
[0-43.5], p=.019), CAC area (4.3 [0-20.3] vs. 0 [0-16.8], p=.025) and number of regions of interest 1 
(2 [2-5] vs. 0 [0-3], p=.014) were all significantly higher in the >2000 MET-min/week versus <1000 2 
MET-min/week group. We also found an increase in CAC score categories (p=.006) across the 3 
exercise volume groups (Figure 2 Panel A). Unadjusted (OR=2.80 (95%CI: 1.47 – 5.32)) and 4 
multivariable adjusted logistic regression analyses (OR=3.20 (95%CI: 1.56 – 6.57)) demonstrated 5 
a significantly higher CAC prevalence in >2000 MET-min/week versus <1000 MET-min/week 6 
(Table 2). However, there were no significant differences in CAC score (p=.20), area (p=.21), 7 
density (p=.25), and regions of interest (p=.20) across exercise volume groups when analyses were 8 
repeated only in participants with CAC>0 (Supplemental Table 3). Also, analysis of CAC location 9 
revealed no differences in the presence of CAC within each coronary vessel and in proximal versus 10 
distal segments (Supplemental Table 3). Analysis of coronary atherosclerosis characteristics 11 
(Supplemental Table 4) showed significant higher plaque prevalence (either calcified, non-12 
calcified, mixed <130 HU or mixed >130HU) in the most active group (77%) versus the least active 13 
group (56%, Figure 2 Panel B). Unadjusted (OR=2.72 (95%CI: 1.37 – 5.39)) and multivariable 14 
adjusted logistic regression analyses (OR=3.35 (95%CI: 1.57 – 7.14)) confirmed these observations 15 
and demonstrated a significantly higher coronary atherosclerosis prevalence in >2000 MET-16 
min/week versus <1000 MET-min/week (Table 3). Also prevalence of plaque appears to be 17 
specifically associated with hours of very vigorous intensity exercise (ORadjusted=1.56 (95%CI: 1.17 18 
– 2.08)), whereas hours of moderate and vigorous intensity exercise did not impact plaque 19 
prevalence. In participants with coronary atherosclerosis, a lower prevalence of mixed plaques 20 
was observed in the most active (48%) versus least active group (69%, Figure 3 Panel A) with 21 
ORadjusted=0.35 (95%CI: 0.15 – 0.85). A difference in the prevalence of mixed plaques <130 HU was 22 
14 
 
responsible for this finding (43% in <1000 MET-min/week, 33% in 1000-2000 MET-min/week and 1 
21% in >2000 MET-min/week group, p=.046) as no differences were observed in the prevalence 2 
of mixed plaques >130 HU across exercise volume groups (41%, 49% and 40% respectively, p=.47). 3 
The lower prevalence of mixed plaques in the highest exercise volume group appears to be largely 4 
mediated by hours of vigorous intensity exercise (ORadjusted=0.83, 95%CI: 0.71 – 0.98), whereas 5 
moderate and very vigorous intensity did not impact plaque morphology. When considering 6 
dominant plaque types (either only calcified, only non-calcified or only mixed plaques), we 7 
observed that the most active group had significantly more often only calcified plaques compared 8 
to the least active group (ORadjusted=3.57 (95%CI: 1.28 – 9.97), Figure 3 Panel B). Other types of 9 
plaque dominance (including mixed plaques <130 HU and >130 HU) did not significantly differ 10 
across exercise volume groups (p>.05). Exercise intensity was also not related to plaque 11 
dominance. Analysis of coronary atherosclerosis location revealed no differences in the presence 12 
of plaques within each coronary vessel and in proximal versus distal segments (Supplemental 13 
Table 4).  14 
Finally, the test for non-linearity for cubic spline regression was non-significant for 15 
presence of CAC (p=.48) and presence of plaque (p=.29), indicating that there was no non-linear 16 
relationship with lifelong exercise volumes. 17 
 18 
DISCUSSION 19 
This study provides new insights in the association between lifelong exercise volumes and 20 
coronary atherosclerosis. Based on the non-contrast CT-scan, we found that participants with 21 
CAC>0 had a higher lifelong exercise volume compared to participants with CAC=0. Logistic 22 
15 
 
regression showed an ORadjusted of 1.02 per MET-hour/week and ORadjusted=3.20 for >2000 MET-1 
min/week versus <1000 MET-min/week for prevalence of CAC>0. CTCA confirmed our CAC data 2 
as we found that the most active group had a significantly higher prevalence of any type of plaque. 3 
However, among individuals with coronary atherosclerosis, a lower prevalence of mixed plaques 4 
and a higher prevalence of only calcified plaques was observed in the most versus least active 5 
athletes. Interestingly, very vigorous intensity exercise was associated with CAC and plaque 6 
presence, and vigorous intensity exercise was associated with reduced prevalence of mixed 7 
plaques. These findings suggest that athletes with the highest exercise volumes more often have 8 
CAC and atherosclerotic plaques, but their plaques are of a more benign composition. 9 
 10 
Accelerated Coronary Artery Calcification 11 
Athletes in the most active group show a higher prevalence of CAC and higher CAC scores. This is 12 
in agreement with a previous study, which showed higher CAC scores in German marathon 13 
runners when they were matched for age and risk factors with controls13. A major limitation of 14 
that study was that the history of the subjects’ cardiovascular risk factors was unknown. 15 
Participants could have recently become runners and reduced their risk factors, however that 16 
would not undo the lifelong process of atherosclerosis. Support for this hypothesis is that 52% of 17 
the runners were former smokers. We quantified lifelong exercise patterns to account for 18 
changes in exercise volume throughout the lifetime (Figure 1) and therefore can determine the 19 
dose-response relationships between exercise exposure and coronary atherosclerosis more 20 
accurately. Athletes in the least active group performed an equivalent of ~1 hour/week of running 21 
throughout their entire lives (669 [405-802] MET-min/week), whereas athletes in the most active 22 
16 
 
group performed an equivalent of ~4 hours/week of running (2724 [2295-3526] MET-min/week). 1 
Our findings support a consistent pattern of an increased prevalence of CAC and CAC scores in 2 
athletes with high exercise volumes.    3 
 4 
CAC and plaque characteristics 5 
Atherosclerotic plaque characteristics can differ, which has an important effect on the risk of 6 
cardiac events. The CAC score is a multiplication of area and density, whereby an increase in area 7 
increases the risk of cardiovascular events and an increase in density lowers the risk of 8 
cardiovascular events 19. We hypothesized that athletes would have similar or higher CAC scores 9 
because of a higher density of their plaques. Analysis in participants with CAC>0 showed that 10 
there was no difference in density across exercise volume groups. These findings emphasize that 11 
CAC characteristics (i.e., area, density, regions of interest and location) were comparable between 12 
exercise volume groups, despite a higher CAC prevalence in the most active athletes.  13 
Our CTCA data revealed additional information on plaque composition. Among 14 
participants with plaques, we found a lower prevalence of mixed plaques and a higher prevalence 15 
of individuals with only calcified plaques in the >2000 MET-min/week group. A previous study 16 
estimated the 3-year probability of major adverse cardiac events at 6% for calcified plaques, 23% 17 
for non-calcified plaques and 38% for mixed plaques in a cohort of patients suspected of having 18 
coronary artery disease3. Therefore, plaque composition (fewer mixed, more only calcified) 19 
seems to be more benign in the most active athletes, which is supported by the lower prevalence 20 
of CVD in athletes4, 5 and the superior life expectancy of elite athletes6.  21 
 22 
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Influence of Exercise Intensity 1 
We found a significant association between hours of very vigorous intensity exercise and 2 
presence of CAC and plaque, and an inverse association between vigorous exercise intensity and 3 
presence of mixed plaque. These observations are in line with findings from previous studies as 4 
extreme exercise appears to be related to cardiac troponin release33, myocardial fibrosis34, and 5 
atrial fibrillation35. It is therefore possible that not the duration of exercise is most important in 6 
the development of coronary atherosclerosis, but specifically the intensity of exercise. In contrast, 7 
epidemiological studies have shown that vigorous intensity exercise is associated with greater risk 8 
reductions in all-cause and cardiovascular mortality compared to moderate intensity exercise36, 9 
37. Alternatively, exercise intensity may be a proxy for overall lifelong exercise volume as the most 10 
active exercisers (>2000 MET-min/week) reported the highest volume of very vigorous intensity 11 
exercise. Future (animal) studies exploring the mechanisms of CAC and plaque development 12 
following exposure to different exercise intensities are therefore needed. 13 
 14 
Potential Underlying Mechanisms  15 
The underlying mechanisms for the higher prevalence of CAC/plaque and its increased 16 
calcification in athletes with the highest exercise volume and intensity are unknown. Hypotheses 17 
for the potential underlying mechanisms include increased exposure to: 1) flexing of the coronary 18 
arteries at high heart rates with disruption of laminar blood flow, 2) high blood pressures during 19 
exercise, 3) increased levels of parathyroid hormone (PTH) due to their exercise training or 4) 20 
hypomagnesemia. Flexing of the coronary arteries during exercise may increase mechanical stress 21 
on the vessel wall and disturb flow patterns38, potentially accelerating atherosclerosis39. High 22 
18 
 
blood pressure accelerates coronary artery calcification 30 and high blood pressures during 1 
exercise may have an influence on atherosclerosis when individuals are exposed for a substantial 2 
amount of time. Exercise is known to acutely increase PTH after exercise40 and this might promote 3 
coronary calcification. Higher levels of PTH correlate with increased risk of atherosclerotic disease 4 
as assessed by whole body magnetic resonance imaging 41. Alternatively, magnesium levels could 5 
also contribute to the increased CAC scores in athletes since magnesium levels are inversely 6 
related to CAC42 and athletes may43 have low magnesium levels. In conclusion, future studies are 7 
warranted to confirm which mechanisms are responsible for the higher CAC / plaque prevalence 8 
in the most active athletes.  9 
 10 
Clinical relevance 11 
Although active athletes have more CAC and plaque, they have fewer mixed plaques and more 12 
often have only calcified plaques. The combination of these plaque types results in a lower risk 13 
profile for future CVD. However, the difference between CAC=0 and CAC>0 is significant, with 14 
estimated 3-year probabilities of major adverse cardiac events of 2.1% for CAC score=0; 13% for 15 
a CAC score between 1 to 100; 16% for CAC score between 101 and 400; and 34% for a CAC score 16 
above 4003. Higher CAC categories were also associated with a higher event rate (CAC <100: 1/69 17 
(1%); CAC 100 to <400: 3/25 (12%); and CAC >400: 3/14 (21%), p=.002) in German marathoners 18 
after 6.2 years of follow-up44. It is therefore prudent to aggressively manage atherosclerotic risk 19 
factors in athletes with high CAC scores, e.g. start with statins. Higher CAC scores may indicate 20 
higher risk in athletes, however it is likely that the athlete’s risk is not similar to that of the general 21 
population. Exercise training increases coronary blood flow by increasing arteriolar diameters 22 
19 
 
and/or density and improves vasomotor reactivity of the coronary resistance arteries45. 1 
Therefore, beneficial vascular adaptations such as an improved coronary flow reserve46, 47 may 2 
also allow athletes to better deal with coronary stenoses and experience fewer symptoms and 3 
events than the general population with a similar plaque burden. Follow-up studies focussed on 4 
clinical outcomes are warranted, to adequately advice athletes and minimalize their risk for future 5 
cardiovascular events. 6 
 7 
Limitations 8 
Limitations of this study include a potential recall bias as we requested the participants’ lifelong 9 
historical exercise pattern. However, these athletes were dedicated exercisers who could 10 
remember their lifelong exercise activity very well and only 7 (2%) of the exercise questionnaires 11 
were incomplete. In addition, recall bias should affect all athletes in our cohort in the same way. 12 
This was an observational study and therefore we cannot exclude the possibility of residual 13 
confounding (from e.g. diet or alcohol intake). Furthermore, we only included recreational and 14 
competitive athletes and did not include a control group from the general population. Therefore, 15 
we cannot make any comparisons with non-athletes. Moreover, we only included men, so our 16 
results cannot be translated to women and follow-up research in female athletes is needed to 17 
allow sex-specific risk-estimation and counselling. Finally, we included only Caucasian men in the 18 
MARC study. As race is known to impact CAC distribution22, findings from our study cannot be 19 
directly extrapolated to athletes of other races.  20 
Recent studies demonstrated that the use of statins can promote calcification of 21 
atherosclerotic plaques29, 48. Therefore, we also analyzed the data excluding participants using 22 
20 
 
statins. This did not materially alter our results so we did not exclude these participants. Diabetes 1 
can accelerate atherosclerosis30 so we also analyzed the data excluding participants with 2 
diabetes. This also did not alter our results so we chose not to exclude these participants.  3 
A strength of our study is how we measured exercise volume. We chose to record lifelong 4 
exercise patterns as atherosclerosis is also a lifelong process49. We only included sports activities, 5 
so physical activity in other domains were not included (work, commuting, gardening, household 6 
activities). Unfortunately, this reduces the comparability of our exercise volumes with other 7 
studies. Another strength of this study is the combined use of both non-contrast CT and CTCA, to 8 
compare both CAC and otherwise non-detected atherosclerotic plaques. 9 
 10 
Conclusion 11 
In this study of middle aged men engaged in competitive or recreational leisure sports, 12 
participants in the >2000 MET-min/week group had a higher prevalence of CAC and 13 
atherosclerotic plaques. The most active group did however have a more benign composition of 14 
plaques, with fewer mixed plaques and more often only calcified plaques. These observations 15 
may explain the increased longevity typical of endurance athletes despite the presence of more 16 
coronary atherosclerosis in the most active participants.   17 
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FIGURE LEGENDS 1 
Figure 1. Patterns of exercise volumes per decade. A gradual age-related increase in exercise 2 
volume was found in each exercise volume group (<1000 / 1000-2000 / >2000 MET-min/week). 3 
Data was averaged per decade and available for all participants (n=284) for decades between age 4 
12 and 50. For decade 50-60 (n=192) and 60-70 (n=64), data was available in a subgroup only. 5 
 6 
 7 
 8 
  9 
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Figure 2. Prevalence of coronary artery calcification and atherosclerotic plaques across lifelong 1 
exercise volume groups. Data were derived from CT and CTCA scans for assessment of CAC and 2 
atherosclerotic plaques (n=284). Panel A shows a comparison of CAC score categories across 3 
exercise volume groups. A significant difference in CAC score categories (p=.006) was found 4 
across exercise volume groups, with higher CAC scores in the >2000 MET-min/week group. The 5 
>2000 MET-min/week group had an adjusted odds ratio of 3.2 (95%CI: 1.6-6.6) for CAC scores >0 6 
compared to the <1000 MET-min/week group. Panel B shows a significant increase of 7 
atherosclerotic plaque prevalence across exercise volume groups (p=.013) with an adjusted odds 8 
ratio of 3.3 (95%CI: 1.6-7.1) for presence of plaque for the >2000 MET-min/week compared to 9 
the <1000 MET-min/week group. CAC = coronary artery calcification; CT = computed tomography; 10 
CTCA = computed tomography coronary angiography; MET = metabolic equivalent of task. 11 
 12 
  1 
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Figure 3.  Plaque characteristics across the lifelong exercise volume groups in participants with 1 
CTCA evidence of coronary atherosclerosis (n=182). The >2000 MET-min/week group had fewer 2 
mixed plaques (panel A) and more often only calcified plaques (panel B). These data suggest that 3 
plaque morphology is different across exercise volume groups, which may translate to a lower 4 
risk for major adverse cardiac events for the most active exercisers, despite their higher 5 
prevalence of coronary atherosclerosis. CAC = coronary artery calcification; CTCA = computed 6 
tomography coronary angiography; MET = metabolic equivalent of task. 7 
 8 
  9 
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Table 1. A comparison of participant and coronary artery calcification characteristics across 1 
exercise volume groups. 2 
           Lifelong exercise volume (MET-min/week)  
 <1000 
(n=88) 
1000-2000 
(n=121) 
>2000 
(n=75) 
P-value 
Participant characteristics     
Age, years 54.4 (6.1) 54.8 (6.3) 55.9 (6.9) .35 
Systolic BP, mmHg 128 (11) 130 (15) 129 (12) .63 
Diastolic BP, mmHg 80 (8) 80 (9) 80 (8) .82 
Height, cm 183 (7) 183 (6) 181 (7) .11 
Weight, kg 84 (11) 83 (10) 80 (9) † .029* 
BMI, kg/m2 25.3 (2.9) 24.8 (2.8) 24.5 (2.3) .14 
BSA, m2 2.06 (.16) 2.05 (.14) 2.00 (.13) † .025* 
Exercise tolerance, Watt 298 (44) 319 (47)† 321 (48)† .001* 
Total Cholesterol, mmol/l 5.36 (.87) 5.31 (.88) 5.44 (.96) .63 
Statin, n (%) 6 (7%) 2 (2%) 7 (9%) .048* 
Current smokers, n (%) 7 (8%) 5 (4%) 2 (3%) .26 
Former smoker, n (%) 32 (36%) 43 (36%) 33 (44%) .46 
Never smoker, n (%) 49 (56%) 73 (60%) 40 (53%) .60 
Pack years of smoking, n 0 [0-8] 0 [0-7] 0 [0-8] .81 
Antihypertensive, n (%) 7 (8%) 7 (6%) 6 (8%) .78 
34 
 
Diabetes, n (%) 1 (1%) 1 (1%) 2 (3%) .55 
Family history of CHD, n (%) 29 (33%) 35 (29%) 25 (33%) .75 
CAC Characteristics     
CAC, Agatston Units 0 [0-43.5] .8 [0-26.5] 9.4 [0-60.9]†‡ .019* 
CAC=0, n (%) 50 (57%) 60 (50%) 24 (32%) .005* 
Area, mm2 0 [0-16.81] .8 [0-10.8] 4.3 [0-20.3]† .025* 
Density, au 3.0 [1.9-3.5] 2.6 [1.6-3.2] 3.0 [2.0-3.4] .25 
Regions of interest, n 0 [0-3] 1 [0-3] 2 [2-5] †‡ .014* 
Lifelong Exercise Characteristics    
Years of exercise§, n 27 [13-37] 36 [30-41]† 40 [35-47]†‡ <.001* 
Sessions/week, n 0.9 [.7-1.4] 2.1 [1.7-2.5]† 3.3 [2.7-4.5]†‡ <.001* 
Duration/session, hrs 1.4 [1.1-1.8] 1.4 [1.2-1.7] 1.7 [1.5-2.0]†‡ <.001* 
Exercise duration/week, hrs 1.5 [.9-1.9] 3.0 [2.4-3.6]† 5.7 [4.6-7.3]†‡ <.001* 
MET-min/week, au 669 [405-802] 1443 [1189-1672]† 2724 [2295-3526]†‡ <.001* 
MET-hours/week, au 11.2 [6.7-13.4] 24.1 [19.8-27.9]† 45.4 [38.2-58.8]†‡ <.001* 
Light intensity, (%) 0 [0-0] 0 [0-0] 0 [0-0] .47 
Moderate intensity, (%) 11 [0-39] 6 [0-23] 0 [0-14]† .035* 
Vigorous intensity, (%) 52 [21-89] 56 [22-86] 67 [32-87] .66 
Very vigorous intensity, % 2 [0-50] 18 [0-53] 23 [3-54]† .036* 
Lifetime MET-hours, au  24257 [13541-
30410] 
52280 [42458-
61098]† 
104208 [81539-
137010]†‡ 
<.001* 
35 
 
Au, arbitrary units; BMI, body mass index; BP, Blood pressure; BSA, body surface area; CAC, 
coronary artery calcification; CHD, coronary heart disease; MET, Metabolic Equivalent of Task. Data 
is presented as mean (SD), n (%) or median [interquartile range]. * = P-value <.05. † = pairwise 
comparison, significantly different from <1000 MET-min/week.‡= pairwise comparison, significantly 
different from 1000-2000 MET-min/week. §= since age 12. 
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Table 2. Unadjusted and multivariable-adjusted associations between lifelong exercise volumes and presence of coronary artery 
calcification (CAC>0). 
 Unadjusted  Model 1*  Model 2†  Model 3‡  
 Odds Ratio 
(95% CI) 
P-value Odds Ratio 
(95% CI) 
P-value Odds Ratio 
(95% CI) 
P-value Odds Ratio 
(95% CI) 
P-value 
Presence of CAC         
MET-hrs/week 1.02 
(1.01 – 1.04) 
.003 1.02 
(1.00 – 1.04) 
.014 1.02 
(1.01 – 1.04) 
.012 1.02 
(1.01 – 1.04) 
.006 
Exercise intensity         
 Moderate intensity 
 (hrs/week) 
1.09  
(0.88 – 1.37) 
.43 1.06 
(0.84 – 1.33) 
.65 1.01 
(0.79 – 1.30) 
.91 1.03  
(0.80 – 1.32) 
.81 
 Vigorous intensity 
 (hrs/week) 
1.16 
(1.01 – 1.32) 
.031 1.12 
(0.97 – 1.28) 
.13 1.12  
(0.97 – 1.29) 
.13 1.13 
(0.97 – 1.31) 
.12 
 Very vigorous intensity 
 (hrs/week) 
1.35 
(1.06 – 1.71) 
.014 1.35 
(1.06 – 1.72) 
.016 1.41  
(1.10 – 1.81) 
.008 1.47 
(1.14 – 1.91) 
.003 
37 
 
MET, Metabolic Equivalent of Task. Each exposure (exercise volume and exercise intensity) was entered separately into the different 
models. *Adjusted for age. † Additionally adjusted for body mass index, systolic blood pressure, ever smoked, use of antihypertensive, 
total cholesterol and family history of coronary heart disease. ‡ Additionally adjusted for use of statin and diabetes.  
  
Exercise volume groups         
          <1000  
          MET-min/week 
Reference  Reference  Reference  Reference  
          1000 – 2000  
          MET-min/week 
1.34 
(0.77 – 2.32) 
.30 1.33 
(0.75 – 2.35) 
.33 1.45 
(0.80 – 2.63) 
.22 1.62 
(.88 – 2.97) 
.12 
          >2000 
          MET-min/week 
2.80 
(1.47 – 5.32) 
.002 2.69 
(1.38 – 5.23) 
.004 2.93 
(1.46 – 5.86) 
.002 3.20 
(1.56 – 6.57) 
.001 
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Table 3. Unadjusted and multivariable-adjusted associations between lifelong exercise volumes and CTCA evidence of coronary 
atherosclerosis. 
 Unadjusted  Model 1*  Model 2†  Model 3‡  
 Odds Ratio 
(95% CI) 
P-value Odds Ratio 
(95% CI) 
P-value Odds Ratio 
(95% CI) 
P-value Odds Ratio 
(95% CI) 
P-value 
Presence of plaque         
MET-hrs/week 1.02 
(1.00 – 1.03) 
.021 1.02 
(1.00 – 1.03) 
.06 1.02 
(1.00 – 1.04) 
.033 1.02 
(1.00 – 1.04) 
.015 
Exercise intensity         
 Moderate intensity 
 (hrs/week) 
1.11  
(0.86 – 1.43) 
.41 1.08 
(0.84 – 1.39) 
.56 1.05 
(0.81 – 1.38) 
.70 1.07  
(0.81 – 1.40) 
.64 
 Vigorous intensity 
 (hrs/week) 
1.10 
(0.96 – 1.26) 
.18 1.06 
(0.92 – 1.23) 
.40 1.08  
(0.93 – 1.26) 
.33 1.08 
(0.93 – 1.27) 
.32 
 Very vigorous intensity 
 (hrs/week) 
1.38 
(1.06 – 1.80) 
.015 1.38 
(1.06 – 1.79) 
.017 1.46  
(1.11 – 1.92) 
.007 1.56 
(1.17 – 2.08) 
.002 
39 
 
MET, Metabolic Equivalent of Task. Each exposure (exercise volume and exercise intensity) was entered separately into the different 
models. *Adjusted for age. † Additionally adjusted for body mass index, systolic blood pressure, ever smoked, use of antihypertensive, 
total cholesterol and family history of coronary heart disease. ‡ Additionally adjusted for use of statin and diabetes. 
 
  
Exercise volume groups         
          <1000  
          MET-min/week 
Reference  Reference  Reference  Reference  
          1000 – 2000  
          MET-min/week 
1.30 
(0.74 – 2.27) 
.36 1.28 
(0.73 – 2.27) 
.39 1.49 
(0.81 – 2.71) 
.20 1.62 
(.88 – 2.99) 
.12 
          >2000 
          MET-min/week 
2.72 
(1.37 – 5.39) 
.004 2.60 
(1.29 – 5.24) 
.007 2.99 
(1.44 – 6.23) 
.003 3.35 
(1.57 – 7.14) 
.002 
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Supplemental Table 1. Frequency of sports participation 
Type of sport Frequency (%) MET-score* 
 Total Dominant sport  
Athletics 41 (14%) 10 (4%) 6.7 
Badminton 14 (5%) 1 (0%) 5.5 
Baseball 4 (1%) 1 (0%) 5 
Basketball 18 (6%) 2 (1%) 6.5 
Bowling 1 (0%) 1 (0%) 3 
Boxing 4 (1%) 0 (0%) 8.7 
Cycling 169 (60%) 81 (29%) 6.8/7.5/8.5/10 
Dancing 2 (1%) 0 (0%) 5 
Diving 2 (1%) 0 (0%) 7 
Fitness/health club/strength 54 (19%) 13 (5%) 3.5/4.5/5.5/7.3/7.8 
Golf/cricket 12 (4%) 6 (2%) 4.8 
Gymnastics 13 (5%) 1 (0%) 3.8/6 
Handball 8 (3%) 2 (1%) 8 
Hockey 36 (13%) 11 (4%) 7.8 
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Horse riding 6 (2%) 2 (1%) 5.5 
Judo/Karate/Jujutsu 20 (7%) 1 (0%) 5.3 
Korfball 7 (3%) 2 (1%) 6.5 
Motor cross 5 (2%) 0 (0%) 4 
Mountain climbing 2 (1%) 1 (0%) 6.6 
Paragliding 2 (1%) 0 (0%) 1.8 
Rowing 21 (7%) 4 (1%) 9.2 
Rugby 4 (1%) 2 (1%) 6.3/8.3 
Running 158 (56%) 72 (25%) 6/7/9.3/11.8 
Sailing/windsurfing 8 (3%) 3 (1%) 3/4.5/5 
Shooting sport 1 (0%) 1 (0%) 4.3 
(Water) Skiing/snowboard 9 (3%) 1 (0%) 5.3/6 
Soccer 109 (38%) 29 (10%) 7 
(Inline) Speed skating 35 (12%) 1 (0%) 7.5/9 
Squash 8 (3%) 1 (0%) 9.7 
Swimming 28 (10%) 3 (1%) 8/10 
Table tennis 10 (4%) 2 (1%) 4 
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Tennis 78 (28%) 10 (4%) 5/7.3 
Triathlon 12 (4%) 5 (2%) 9.8 
Ultimate Frisbee 2 (1%) 0 (0%) 8 
Volleyball 22 (8%) 3 (1%) 4/6 
Walking 6 (2%) 2 (1%) 4.3 
Water polo 17 (6%) 10 (4%) 10 
MET: Metabolic Equivalent of Task; *MET-score can differ based on level of competition and 
specific type of sport (e.g. cycling can be racing/spinning/touring/etc.) 
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Supplemental Table 2. Participant characteristics of the total study population as well as 
athletes with and without coronary artery calcification.  
 Total population 
(n=284) 
Without CAC  
(n=134) 
With CAC  
(n=150) 
P-value 
Participant Characteristics     
Age, years 55.0 (6.5) 53.2 (5.7) 56.6 (6.8) <.001* 
Systolic BP, mmHg 129 (13) 127 (13) 131 (13) .003* 
Diastolic BP, mmHg 80 (8) 79 (8) 81 (8) .033* 
Height, cm 182 (7) 183 (7) 182 (6) .35 
Weight, kg 83 (10) 82 (10) 83 (10) .66 
BMI, kg/m2 24.9 (2.7) 24.7 (2.6) 25.1 (2.8) .22 
BSA, m2 2.04 (.14) 2.04 (.14) 2.04 (.14) .98 
Exercise tolerance, Watt 313 (47) 313 (45) 313 (50) .96 
Total cholesterol, mmol/l 5.4 (0.9) 5.2 (0.9) 5.5 (0.9) .004* 
Statin, n (%) 15 (5%) 1 (1%) 14 (9%) .001* 
Current smokers, n (%) 14 (5%) 8 (6%) 6 (4%) .44 
Former smoker, n (%) 108 (38%) 42 (31%) 66 (44%) .03* 
Never smoker, n (%) 162 (57%) 84 (63%) 78 (52%) .07 
Pack years of smoking, n 0 [0-8] 0 [0-7] 0 [0-8] .21 
Antihypertensive, n (%) 
Diabetes, n (%) 
20 (7%) 
4 (1%) 
6 (5%) 
2 (2%) 
14 (9%) 
2 (1%) 
.11 
.91 
Family history of CHD, n (%) 89 (31%) 34 (25%) 55 (37%) .041* 
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CAC Characteristics     
CAC, Agatston Units .9 [0-42.1] - 35.8 [9.3-145.8] - 
Area, mm2  .9 [0-15.0] - 13.0 [4.5-44.1] - 
Density, au  2.8 [1.8-3.4] - 2.8 [1.8-3.4] - 
Regions of interest, n 1 [1-4] - 3 [1-10] - 
Lifelong Exercise Characteristics    
Years of exercise training†, n 36 [27-42] 35 [23-39] 37 [31-45] <.001* 
Sessions/week, n 1.9 [1.3-2.8] 1.8 [1.2-2.6] 2.0 [1.5-3.0] .019* 
Duration/session, hrs 1.5 [1.2-1.8] 1.5 [1.2-1.8] 1.5 [1.3-1.8] .20 
Exercise duration/week, hrs 2.9 [1.9-4.4] 2.6 [1.7-3.8] 3.1 [2.1-4.7] .012* 
MET-min/week, au 1356 [851-2030] 1225 [749-1782] 1528 [997-2248] .003* 
MET-hours/week, au 22.6 [14.2-33.8] 20.4 [12.48-29.7] 25.5 [16.6-37.5] .003* 
Light intensity, (%) 0 [0-0] 0 [0-0] 0 [0-0] .18 
Moderate intensity, (%) 4 [0-27] 4 [0-24] 6 [0-31] .58 
Vigorous intensity, (%) 59 [23-87] 66 [27-90] 55 [20-82] .19 
Very vigorous intensity, % 16 [0-53] 13 [0-51] 19 [0-54] .39 
Lifetime MET-hours, au  50290 [32431-
76462] 
41526 [26716-
65149] 
56259 [34682-
89679] 
<.001* 
Au, arbitrary units; BMI, body mass index; BP, Blood pressure; BSA, body surface area; CAC, 
coronary artery calcification; CHD, coronary heart disease; MET, Metabolic Equivalent of Task. 
Data is presented as mean (SD), n (%) or median [interquartile range]. *=P-value <.05. †= since 
age 12. 
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Supplemental Table 3. A comparison of participant and coronary artery calcification (CAC) 
characteristics across exercise volume groups in participants with CAC>0. 
           Lifelong exercise volume (MET-min/week)  
 <1000 
(n=38) 
1000-2000 
(n=61) 
>2000 
(n=51) 
P-value 
CAC, Agatston Units 69.6 [13.8-331.5] 24.1 [6.5-85.5] 39.2 [8.4-159.0] .20 
Area, mm2  22.0 [7.8-99.3] 10.5 [3.7-30.0] 12.4 [4.1-53.0] .21 
Density, au  3.0 [1.9-3.5] 2.6 [1.6-3.2] 3.0 [2.0-3.4] .25 
Regions of interest, n 5 [2-16] 3 [1-7] 4 [2-10] .20 
Location of CAC, n (%)     
      Left anterior descending 34 (90%) 53 (87%) 43 (84%) .78 
      Ramus circumflexus 13 (34%) 23 (38%) 20 (39%) .89 
      Right coronary artery 17 (45%) 22 (36%) 21 (41%) .68 
      Proximal segments* 32 (84%) 49 (80%) 39 (77%) .66 
Au, arbitrary units; CAC, coronary artery calcification; Data is presented as median [interquartile 
range] or n (%). * = proximal segments defined as segments 1,5,6 and 11 1. 
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Supplemental Table 4. A comparison of plaque characteristics across exercise volume groups in 
participants with computed tomography coronary angiography evidence of atherosclerotic 
plaques. 
 Lifelong exercise volume (MET-min/week)  
 <1000 
(n=49) 
1000-2000 
(n=75) 
>2000 
(n=58) 
P-value 
Presence of plaques      
      Calcified, n (%) 31 (63%) 44 (59%) 41 (71%) .36 
      Non-Calcified, n (%) 18 (37%) 25 (33%) 16 (28%) .59 
      Mixed (both), n (%) 34 (69%) 53 (71%) 28 (48%) .017* 
              Mixed < 130 HU, n (%) 21 (43%) 25 (33%) 12 (21%) .046* 
              Mixed >130 HU, n (%)  20 (41%) 37 (49%) 23 (40%) .47 
Dominant plaque types     
      ONLY Calcified, n (%) 8 (16%) 10 (13%) 22 (38%) .002* 
      ONLY Non-Calcified, n (%) 3 (6%) 6 (8%) 4 (7%) .92 
      ONLY Mixed (both), n (%) 9 (18%) 22 (29%) 10 (17%) .18 
              ONLY Mixed >130 HU, n (%)  3 (6%) 10 (13%) 5 (9%) .39 
              ONLY Mixed <130 HU, n (%) 5 (10%) 7 (9%) 3 (5%) .58 
Location of plaques     
      Left anterior descending, n (%) 47 (96%) 67 (89%) 49 (85%) .16 
      Ramus circumflexus, n (%) 18 (37%) 26 (35%) 24 (41%) .73 
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      Right coronary artery, n (%) 24 (49%) 29 (39%) 27 (47%) .47 
      Proximal segments† , n (%) 43 (88%) 64 (85%) 45 (78%) .32 
HU = Hounsfield Units; *=P-value <.05. †=  = proximal segments defined as segments 1,5,6 and 
111.  
 
